Updates are available Erratum dated 2014-09-30
Click to view Erratum: https://doi.org/10.1038/tp.2014.74
-
Authors
Levey, D F
Le-Niculescu, H
Frank, J
Ayalew, M
Jain, N
Kirlin, B
Learman, R
Winiger, E
Rodd, Z
Shekhar, A
Schork, N
Kiefe, F
Wodarz, N
Müller-Myhsok, B
Dahmen, N
,
Nöthen, M
Sherva, R
Farrer, L
Smith, A H
Kranzler, H R
Rietschel, M
Gelernter, J
Niculescu, A B
- License Information
-
More Information
Article History
Received: 23 January 2014
Accepted: 18 March 2014
First Online: 20 May 2014
Competing interests
: The authors declare no conflict of interest directly related to this work. Although not directly relevant to this work, HRK has been a consultant or advisory board member with Alkermes, Lilly, Lundbeck, Pfizer, and Roche. He has also received honoraria from the Alcohol Clinical Trials Initiative (ACTIVE) of the American Society of Clinical Psychopharmacology, which is supported by Lilly, Lundbeck, AbbVie and Pfizer.
